Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of VVZ-149 in Lumbar Radiculopathy
NCT02644421Phase 1Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of opiranserin in lumbar radiculopathy (3 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Number of subjects with treatment-related Adverse Events at 8 hours. Started Nov 2015; status: completed.
02
Drugs
opiranserin
03
Conditions
lumbar radiculopathy
Beyond the preview
Go deeper on NCT02644421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644421.